AWM
BIIB icon

AE Wealth Management’s Biogen BIIB Stock Holding History

AE Wealth Management’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$353K Sell
1,633
-34
-2% -$6.5K ﹤0.01% 1392
2026
Q1 		$306K Sell
1,667
-47
-3% -$8.66K ﹤0.01% 1368
2025
Q4 		$302K Buy
1,714
+252
+17% +$41.2K ﹤0.01% 1308
2025
Q3 		$205K Buy
+1,462
New +$198K ﹤0.01% 1392
2025
Q2 		– Sell
-1,731
Closed -$237K – 2172
2025
Q1 		$237K Buy
1,731
+141
+9% +$20.2K ﹤0.01% 1205
2024
Q4 		$243K Buy
+1,590
New +$268K ﹤0.01% 1188
2024
Q3 		– Sell
-1,118
Closed -$259K – 1241
2024
Q2 		$259K Buy
+1,118
New +$243K ﹤0.01% 1078
2024
Q1 		– Sell
-2,014
Closed -$493K – 1222
2023
Q4 		$493K Buy
2,014
+348
+21% +$85.5K ﹤0.01% 1446
2023
Q3 		$428K Buy
1,666
+398
+31% +$106K ﹤0.01% 1461
2023
Q2 		$361K Sell
1,268
-79
-6% -$23.5K ﹤0.01% 1533
2023
Q1 		$374K Buy
1,347
+493
+58% +$136K ﹤0.01% 1462
2022
Q4 		$236K Sell
854
-20,042
-96% -$5.66M ﹤0.01% 1605
2022
Q3 		$5.58M Buy
+20,896
New +$4.44M 0.04% 410
2021
Q4 		– Sell
-1,085
Closed -$307K – 1696
2021
Q3 		$307K Buy
1,085
+277
+34% +$90.8K ﹤0.01% 1357
2021
Q2 		$280K Sell
808
-12,707
-94% -$3.85M ﹤0.01% 1365
2021
Q1 		$3.78M Buy
13,515
+5,953
+79% +$1.61M 0.04% 379
2020
Q4 		$1.85M Sell
7,562
-6,352
-46% -$1.64M 0.02% 516
2020
Q3 		$3.95M Buy
13,914
+7,477
+116% +$2.09M 0.06% 274
2020
Q2 		$1.72M Buy
6,437
+4,524
+236% +$1.36M 0.03% 451
2020
Q1 		$605K Sell
1,913
-41
-2% -$12.4K 0.01% 623
2019
Q4 		$580K Buy
1,954
+380
+24% +$105K 0.01% 691
2019
Q3 		$366K Sell
1,574
-2,111
-57% -$492K 0.01% 711
2019
Q2 		$862K Buy
3,685
+2,683
+268% +$620K 0.03% 447
2019
Q1 		$237K Buy
+1,002
New +$316K 0.02% 548

Other funds holding BIIB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

AE Wealth Management's BIIB Position: Q2 2026 in Review

AE Wealth Management reduced its Biogen (BIIB) stake by 2% in Q2 2026, selling an estimated $6.5K and leaving 1,633 shares worth $353K. The position accounts for ﹤0.01% of the portfolio, ranked #1392.

AE Wealth Management first reported a position in BIIB in Q1 2019 and has held it in 24 quarters since. The position peaked at $5.58M in Q3 2022. 1,046 funds tracked by Wall St. Rank hold BIIB as of Q2 2026.

  • AE Wealth Management held 1,633 shares of Biogen worth $353K as of Q2 2026.
  • AE Wealth Management sold 34 Biogen shares in Q2 2026, an estimated $6.5K.
  • Biogen made up ﹤0.01% of AE Wealth Management's portfolio in Q2 2026, its #1392 holding.
  • AE Wealth Management first reported a position in Biogen in Q1 2019 and has held it in 24 quarters since.
  • AE Wealth Management's Biogen position peaked at $5.58M in Q3 2022.
  • 1,046 funds tracked by Wall St. Rank held Biogen as of Q2 2026.

Based on AE Wealth Management's 13F filing for Q2 2026, filed 3 Aug 2026.